New Risk-Assessment Scorecard Aims to Identify Indian Women at Higher Risk of Bone Fractures
Researchers highlight the importance of earlier osteoporosis risk assessment among women over 50.
A report on a proposed screening scorecard highlights efforts to identify Indian women at increased risk of bone fractures. It discusses the importance of recognising osteoporosis risk before fractures occur and identifying women who may need further bone-density testing.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Osteoporosis is a condition in which bones become weaker and more vulnerable to fractures. It is particularly important in women after menopause because declining oestrogen levels can accelerate bone loss.
Many people with osteoporosis do not experience symptoms until a fracture occurs. Fractures involving the hip, spine and wrist can cause pain, disability, reduced mobility and loss of independence.
The reported scorecard initiative aims to help identify Indian women who may have a higher risk of bone fractures. Risk assessment can consider factors such as age, menopausal status, previous fractures, body weight, family history and other medical conditions.
Identifying higher-risk individuals may help healthcare professionals recommend further evaluation, including bone mineral density testing using dual-energy X-ray absorptiometry, commonly known as DXA.
Early identification can support appropriate interventions such as resistance exercise, adequate calcium and vitamin D intake, fall prevention and medication when clinically indicated.
A risk scorecard is a screening aid rather than a definitive osteoporosis diagnosis. Women with concerning risk factors should discuss appropriate testing with their healthcare providers.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
